(Q46671899)
Statements
1 reference
A randomized, double-blind, phase IIa dose-finding study of Vandetanib (ZD6474) in Japanese patients with non-small cell lung cancer (English)
1 reference
Katsuyuki Kiura
1 reference
Masahiro Tsuboi
1 reference
Kazuhiko Nakagawa
1 reference
Tetsu Shinkai
1 reference
Kenji Eguchi
1 reference
Yuichiro Ohe
1 reference
Nobuyuki Yamamoto
1 reference
Soichiro Yokota
1 reference
Takashi Seto
1 reference
Haiyi Jiang
1 reference
Kazuto Nishio
1 reference
Nagahiro Saijo
1 reference
Masahiro Fukuoka
1 reference
1 April 2008
1 reference
3
1 reference
4
1 reference
386-393
1 reference